Reports/Posters/Strategy/Slide Decks/Peer-Review Publications/Multimedia
(Data/articles are either in public domain or published)
Press Play on the Publication
Strategy
Click on Slide Deck to View
Select Slide Decks
Click on Slide Decks to View
Select Publications
(eg, The Lancet, Allergy, Diabetes Care)
Immunology (British Journal of Dermatology): Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial
Immunology (The Lancet): IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study
Oncology (Lung Cancer): Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer
Oncology (Cancer and Metastasis Reviews): Current perspectives on bone metastases in castrate-resistant prostate cancer
Dermatology (JACI): Urticaria Exacerbations and Adverse Reactions in Patients with Chronic Urticaria Receiving COVID-19 Vaccination: Results of the UCARE COVAC-CU Study
Dermatology / Immunology (Allergy): Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
Neurology (Cancer Treatment Reviews): Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron)
Diabetes (Diabetes Care): HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin
HEOR (Therapeutic Advances Medical Oncology) : Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50